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Abstract 
 
Objective: To examine the psychological and social adjustment of men with early or 
advanced stage prostate cancer and to compare them with a matched group of cancer-
free community volunteers. 
Methods: A longitudinal observational study in which 367 men recently diagnosed with 
early (N = 211) or advanced stage (N = 156) prostate cancer were compared to 169 
cancer-free men from the community, of similar age and residential area, using self-
report measures of psychosocial adjustment. 
Results: On the mental health subscales of the SF-36, men with advanced disease had 
lower vitality and social functioning than the other two groups, and lower mental health 
scores than the comparison group. Both patient groups had lower role-emotional scores 
than the comparison group. With regard to the Brief Symptom Inventory, the advanced 
disease group had higher somatisation scores, and lower interpersonal sensitivity and 
paranoid ideation scores than the early stage group and the community comparison 
group. In terms of psychiatric morbidity, there were higher rates of anxiety disorders but 
not depressive disorders in both patient groups although overall diagnosis rates were 
low. No differences were found in terms of couple or family functioning. 
Conclusions: The results reveal impairment in psychosocial function in men with 
prostate cancer, particularly those with advanced disease, but no increase in the rate of 
formal psychiatric disorder or adverse effects on the couples and families. They suggest 
directions for psychosocial interventions with these patient groups.  
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Prostate cancer (PCA) is the most commonly occurring cancer and the second 
major cause of cancer deaths in Australian men [1],  even though a majority of sufferers 
will survive for a decade or more following diagnosis. Despite its significance for men’s 
health, far less is known about the psychosocial impact of PCA and its treatment than is 
the case in breast cancer [2]. 
Research directed at quality of life in PCA has focused mainly on physical aspects 
of well-being, such as the side effects of treatment, rather than the psychological facets, 
including emotional distress. Given the trajectory of the disease and its many effects on 
sufferers, the psychological and social adjustment of men with PCA is likely to be 
complex. Longitudinal studies of men’s psychological reactions to living with the 
disease are particularly valuable in terms of understanding these complexities [2]. 
Psychosocial adjustment is likely to vary according to disease stage. Most early 
stage diagnoses emerge on routine check-ups that include prostate-specific antigen 
(PSA) testing. Many men will not experience symptoms and be unaware that they have 
problems [3]. Others may have relatively mild symptoms, such as bladder outflow 
obstruction, which they attribute to aging rather than cancer. In contrast, those whose 
disease has advanced (metastatic) may present with bone pain or other symptoms of 
spread. Or again, they may be asymptomatic, with disease advancement detected by a 
routine PSA check. Therefore, it is crucial to consider stage of disease in analysing 
psychological and social adjustment. 
Several treatment options for PCA exist, with debate about the optimal indications 
for each. All are capable of affecting patient wellbeing. Options for localised disease 
include radical prostatectomy, external beam radiotherapy, transperineal brachytherapy 
or regular monitoring of progress without administering any active treatment [4]. 
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Treatment for advanced disease is mostly androgen ablation and, later, chemotherapy 
and radiotherapy. Androgen ablation results in loss of libido, diminished genital 
sensation, loss of a firm erection, and limited return to sexual activity [5]. Body image 
changes, related to effects such as hot flushes and gynaecomastia, may lead to 
emotional distress. Overall, side effects, particularly urinary incontinence, impotence 
and bowel symptoms, are common, and have psychosocial implications [2]. 
One crucial limitation of much research in this field is the lack of an appropriate 
comparison group [2]. Controlled studies are uncommon. Psychosocial problems in 
PCA patients could be due to other factors such as socio-economic concerns or fears of 
aging, while depression could represent grieving for family members or friends who 
have died or become seriously ill. To address this limitation, we included men recruited 
from the community, of similar age and residential area, currently free of cancer. 
Our aim is to report the initial data from a longitudinal study of psychosocial 
adjustment in men with early stage and advanced PCA, following diagnosis, compared 
to men from the community, of similar age and residential area. We hypothesised 
poorer psychosocial adjustment in patients with advanced disease, and poorer 
adjustment in both patient groups than in the comparison group. 
 
METHOD 
Participants 
We recruited cohorts of men differentiated by PCA disease stage and treatment 
method. Newly diagnosed patients with either early or advanced stage PCA  attending 
participating clinics were invited to take part before receiving any definitive treatment. 
Inclusion criteria for the early stage group included histologically confirmed PCA, T1-
T3, N0, M0. For advanced disease, the criterion was evidence of spread to lymph nodes 
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or elsewhere, thus N1 or M1. Exclusion criteria included inability to give informed 
consent, diagnosis of another cancer, minimal understanding of English, psychosis, 
intellectual disability or dementia. In the early stage category, recruitment was initially 
monitored to ensure comparable numbers of ‘watchful waiting’, surgery and 
radiotherapy treatment conditions, and in the advanced group, good representation of 
hormone-responsive, newly progressive, and hormone-resistant and progressive sub-
groups.  Community comparisons were men of similar age and residential areas, 
randomly selected from the phone directory and invited by telephone to take part. Their 
exclusion criteria included any current cancer diagnoses, although other states of ill-
health were not exclusionary. 
Design 
The research committees in all participating hospitals granted ethics approval. 
Research assistants obtained informed consent from eligible men who had expressed a 
willingness to participate. They administered self-report questionnaires, face-to-face 
whenever possible, and assisted with interpretation of items as necessary. Completion of 
questionnaires took around 30 to 45 minutes. In order to avoid excessive burden on the 
men at the time of the PCA diagnoses, we undertook the structured psychiatric 
interview by telephone up to three months later. The CIDI computer software generated 
DSM-IV psychiatric diagnoses from their responses. 
Measures 
Self-report measures included: 
Short-Form 36 Health Survey 
The Short-Form 36 Health Survey (SF-36) [6] is a well-validated and reliable [7] 
measure both of physical and mental aspects of health-related quality of life.  It has 
  Prostate cancer and Psychosocial Adjustment 
  6 
eight subscales, four covering physical health, and four relating to mental health, which 
are used here. Vitality refers to the balance of energy and fatigue levels. Social 
functioning is related to performance of normal social activities without interference 
from physical or emotional problems. Role-emotional refers to performance of work or 
other daily activities without interference. Mental health is related to the balance 
between feelings of nervousness and depression and feeling peaceful, happy and calm. 
Low scores on these subscales indicate poorer functioning. 
Brief Symptom Inventory 
The Brief Symptom Inventory (BSI-53) [8], comprising 53 items covering diverse 
psychological symptoms, has good reliability (e.g., coefficient alphas of .68 to .91), and 
established convergent and predictive validity [9]. It has been extensively used with 
cancer populations. The BSI-53 has nine subscales and a General Severity Index (GSI). 
Dyadic Adjustment Scale 
A short form, comprising 7 questions, of the Dyadic Adjustment Scale (DAS), 
was used. The first 6 items comprise a subscale for marital satisfaction (reliability 0.96) 
[10]; higher scores indicate better relationship adjustment, with the potential range from 
0-30.  
Family Relationships Index 
The Family Relationships Index (FRI) is used to measure cardinal features of 
family functioning [11]. It contains three subscales of four items each, covering 
cohesiveness, expressiveness, and conflict. A total score, within a range of 0-12, 
indicates level of family functioning. Families dealing with cancer find it acceptable and 
it is reliable and valid in this context [12]. 
Composite International Diagnostic Interview (CIDI) 
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We used the anxiety and depression modules of the CIDI [13], since these 
psychiatric categories are the most common in cancer patients. The CIDI generates 
psychiatric diagnoses according to criteria of the Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition (DSM-IV) [14], and has confirmed reliability [15] and 
validity [13]. The CIDI take account of symptoms associated with physical illness 
(including cancer and its treatments) when determining depression or anxiety diagnoses.  
Statistical Analysis 
Descriptive statistics for the patient groups were examined to exclude effects of 
site and treating clinician. As no significant differences emerged, they were combined 
for further analyses. Multivariate Analyses of Variance (MANOVA) were conducted 
using the SPSS 14.0 software package [16] to detect any differences between the three 
groups. Post-hoc Scheffe tests determined the direction of significance. 
RESULTS 
Respondents 
Initially, 367 men with early (211, 57.5%) or advanced stage (156, 42.5%) PCA 
took part. The community comparison group comprised 169 men who were free from 
PCA. Details of their sociodemographic characteristics are summarised and compared 
in Table 1. A greater proportion of the advanced group were retired and they were older, 
on average, than the early and the comparison group. Splitting the comparison group at 
the median age revealed there were no differences in age between the advanced disease 
and older of the two subgroups.   No other differences were apparent. This suggests that 
differences were essentially disease related and further analyses were conducted using 
the original three categories. 
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Insert Table 1 about here 
 
Clinical features 
According to medical records, at recruitment, 57.5% of patients had early stage 
and 42.5% had advanced disease. The majority of the clinical sample (80%) had not had 
cancer before their prostate diagnosis. Gleason scores ranged from 2 to 10, with the 
modal score 6-7 (59%). Mean Gleason scores for the early group (6.5 ± 1.2) differed 
significantly from the advanced disease group (7.8 ± 1.3). Mean prostate-specific 
antigen (PSA) values at baseline were 84.9 (± 332.4). Non-parametric analysis showed 
that the advanced disease values were significantly greater than those of the early group. 
Metastases had occurred for 41%: one third had bone, one sixth nodal, and 6% visceral. 
In terms of treatment, 17% had been in a watchful waiting condition, 53% radiotherapy, 
and 30% surgery. Over 50% of those with metastatic disease were receiving hormone 
therapy in the form of LHRH analogues and 45% anti-androgens. 
Psychosocial adjustment 
Descriptive statistics for each of the three groups on the self-report measures and 
their subscales appear in Table 2.  
 
Insert Table 2 about here 
 
Differences between the three groups on all four mental health subscales of the 
SF-36 were significant. For the vitality and social functioning subscales, the differences 
were between the advanced group and both the other two groups. For the role-emotional 
subscale, the differences were between both the two clinical groups and the comparison 
group. For the mental health subscale, the advanced and comparison groups differed 
significantly. 
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Global distress, as measured by the General Severity Index of the BSI, did not 
differ significantly between the three groups. However, subscale scores revealed 
significant differences for men with advanced stage PCA compared to both the early 
PCA and comparison groups on somatic symptom distress, interpersonal sensitivity and 
paranoid ideation. 
Analyses of the DAS and the FRI scores revealed no significant differences 
between the comparison, early and advanced groups. 
Insert Table 3 about here 
 
Psychiatric morbidity 
Diagnostic rates, derived from the CIDI interviews, are summarised in Table 3. 
Rates overall were low, with no difference in the prevalence of depressive disorders, but 
a slight increase in the rates of anxiety disorders for early (n = 11, 5.2%) and advanced 
stage (n = 9, 5.8%) PCA compared to the comparison group (n = 6, 3.6%).  
 
DISCUSSION 
Our aim was to examine differences in psychosocial adjustment between men 
with early and advanced stage PCA shortly after diagnosis, and those in a community 
comparison group. In terms of psychiatric disorder, few differences emerged. Rates of 
depression and anxiety were low overall, and although anxiety disorders were a little 
higher in the patient groups, the difference was not as great as might be anticipated 
given the men’s serious illnesses. Taken together, the results suggest that diagnosis of 
PCA does not contribute directly to an increased prevalence of diagnosable psychiatric 
states.  
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This picture differs markedly from that encountered in women facing a diagnosis 
of breast cancer [17]. The differences are possibly related to men with PCA being 
diagnosed at a much later point in the life cycle [2] and their relatively lesser biological 
vulnerability to affective disorder. Coping strategies they deploy to deal with the major 
stressor of cancer diagnosis [18] may also play a role. Men may be more inclined to 
construe treatment, an active problem-solving strategy, as a solution to their problems 
and be less concerned with the meaning of the complex and dynamic events that 
represent adaptation to a major chronic, and potentially lethal, illness [19]. Finally, 
several studies have shown that the physical side-effects of treatment used in PCA 
become the focus of patients’ emotional preoccupations [2].  
All four psychosocial dimensions of the SF-36 -- vitality, social functioning, role-
emotional, and mental subscales -- were significantly affected by a diagnosis of PCA. 
The questionnaire revealed notable differences between the groups in terms of social 
and emotional reactions, demonstrating that men with PCA do experience forms of 
psychological distress, even if they do not meet criteria for a diagnosable psychiatric 
disorder. Previous research using the SF-36 with prostate cancer patients has produced 
mixed results. In one major study, men with PCA reported some psychological 
symptoms, but these were at a similar level to those found in healthy controls [20]; in 
another sample, psychological aspects were affected as much as the physical ones [21]. 
In the current study, men with advanced stage PCA had lower vitality and poorer social 
functioning than the other two groups and their mental health scores were lower than 
those of the comparison group. Both clinical groups were more affected than the 
controls in terms of emotional role. These reactions point to burdens borne by the men 
(and possibly their partners), as they struggle with physical problems in the aftermath of 
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treatment [22]. As mentioned below, appropriate psychosocial intervention at this 
critical juncture might facilitate patients developing more effective coping strategies for 
the stresses they face. 
On the BSI subscales, men with advanced stage PCA had higher somatisation 
scores (a greater physical symptom burden, as one would expect), but lower 
interpersonal sensitivity and paranoid ideation levels than both early stage patients and 
the comparison group. While the latter finding might mean that the men become more 
self-focussed as a result of their condition, it also suggests that those with advanced 
disease might experience less social discomfort about the disease and its effects and are 
less vulnerable to perceived social criticism. Men with PCA who are psychologically 
distressed have difficulty discussing their condition with others [23]. If their distress is 
related to perceived social criticism, it might explain why they are less likely to talk 
about their condition with others. This, in turn, may impede the ‘processing’ (a term 
familiar to those working in trauma-related areas) of their experiences with members of 
their support networks, a coping strategy which typically has the effect of reducing 
distress [23].  
We were surprised that no differences emerged between the three groups in terms 
of couple adjustment and family relationships, key spheres of psychosocial functioning. 
Couples and family members in our sample might have enjoyed sufficiently robust 
relationships to be able to deal with the stresses of diagnosis and initial treatment and 
cope effectively, foster closeness and elicit a sense of mutual support. Alternatively, 
men’s partners might be better able to communicate any distress the couple or family 
experience. In a related study, we have produced preliminary results that support this 
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likelihood [24]. Continuing psychosocial distress may exert a long-term deleterious 
effect on relationships, a possibility that deserves closer study.  
It is also possible that the measures we used were not sensitive enough to capture 
the types of dysfunction that result from the diagnosis and treatment of PCA. The need 
for a more sophisticated measure of intimacy and communication stands out in this 
context. A qualitative approach in which interview-derived data are analysed is more 
likely to reveal unique dimensions of relational distress than conventional measures of 
adjustment. 
It should be noted that the time difference between participants’ completing the 
distress measures (at recruitment) and the CIDI interview (up to three months later) may 
also help account for the discrepancies between the two indices. The delay was designed 
to reduce the initial burden of participation at a very sensitive time for the men and also 
to allow for diagnoses that include a time specification (e.g., major depression). 
However, consistent with crisis theory [25], it is possible that any initial distress 
reactions to the acute stressor of receiving a diagnosis would have been captured by the 
self-report but would have settled by the time of the interview. This explanation would 
not account for all the findings, because the overall level of distress soon after diagnosis 
was lower than expected based on comparable studies of other cancer patient groups. 
Further research of men’s reactions to diagnosis of prostate cancer is required to address 
this question. 
Other limitations of the study include recruiting participants via clinics may have 
introduced potential selection bias since not every patient has an equal chance of being 
involved.  Recruitment of consecutive clinic attendees is an accepted form of sampling 
in psycho-oncology research, as it represents a practical way to access PCA cases at a 
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critical juncture. Alternative methods face other potential hazards. Sampling through 
cancer registries may reduce selection bias, but creates inevitable delays at the time 
when men are dealing psychologically with diagnosis.  Seeking recruits through 
advertisements, at information sessions, or from self-help group members, risks 
potential self-selection bias.  
Given the above findings, we cannot but be impressed by the resilience of the men 
in both PCA groups. Yet, as we follow these men (research we have in progress), we 
anticipate that treatment side effects such as incontinence, erectile dysfunction and 
bowel symptoms, and related psychosocial forces, may have adverse effects on health-
related quality of life [2].  These will no doubt in turn become the focus of greater 
clinical and research attention.  Psychosocial interventions and supportive care for men 
with PCA is not widespread currently, possibly because men’s needs are not fully 
understood. While research progress of this kind has been made in relation to women 
with breast cancer, the full picture in PCA remains to be drawn. The data we have 
reported here, complemented with our follow up investigation, will help shed light on 
how we can best assist both patients and their partners. 
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Table 1 
Sociodemographic characteristics of men with early stage cancer and advanced prostate 
cancer, and in the community comparison group. 
 
 Early Advanced Comparison P value 
Age  
- mean + SD 
- range 
 
 
66.15 + 8.26 
43 - 92 
 
70.11 + 9.73 
42 – 90 
 
64.23 + 10.13 
41-89 
 
p < .0001 
Marital status 
- married/defacto 
- single/widowed/ 
divorced/separated 
 
 
78.3% 
 
21.7% 
 
83.0% 
 
17.0% 
 
82.1% 
 
17.9% 
 
p = .47 
Occupational status 
- employed 
- retired/unemployed/
pension 
 
 
36.8% 
 
63.2% 
 
19.3% 
 
80.7% 
 
44.4% 
 
55.6% 
 
p < .0001 
Country of birth 
- Australia & New 
Zealand 
- UK & Ireland 
- European 
- Elsewhere 
 
 
 
78.5% 
  7.5% 
10.5% 
  3.5% 
 
 
 
73.8% 
  6.9% 
13.8% 
  5.5% 
 
 
77.9% 
12.9% 
  4.9% 
  4.3% 
 
 
p = .08 
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Table 2 
Means and standard deviations for men with early stage cancer and advanced prostate cancer, and in the community comparison group, on 
measures of psychosocial adjustment and MANOVA and post hoc analyses of differences between them. 
MEASURE 
Early 
Mean  (SD) 
Advanced 
Mean  (SD) 
Comparison 
Mean  (SD) 
MANOVA Analysis Post Hoc Analyses 
SF-36 vitality 67.06 (19.71) 52.52 (23.20) 67.06 (18.28) F (2, 515) = 27.10***, partial η2 = .095 Advanced < Early, Comparison 
SF-36 social functioning 83.21 (21.85) 74.16 (27.21) 86.97 (19.29) F (2, 515) = 17.06***, partial η2 = .062 Advanced < Early, Comparison 
SF-36 role-emotional 79.41 (35.03) 73.38 (37.76) 88.49 (25.41) F (2, 515) = 8.33***, partial η2 = .031 Early, Advanced < Comparison 
SF-36 mental health 77.78 (17.56) 75.73 (17.86) 80.92 (14.58) F (2, 515) = 3.86*, partial η2 = .015 Advanced < Comparison 
      
BSI  somatisation .31 (.42) .60 (.57) .37 (.51) F (2, 525) = 15.28***, partial η2 = .055 Early, Comparison < Advanced 
BSI  obsessive compulsive .57 (.61) .62 (.61) .57 (.49) N. S.  
BSI  interpersonal sensitivity .39 (.44) .27 (.45) .39 (.52) F (2, 525) = 5.49**,  partial η2 = .020 Advanced < Early, Comparison 
BSI  depression .32 (.48) .32 (.48) .32 (.49) N. S.  
BSI  anxiety .30 (.50) .29 (.46) .30 (.41) N. S.  
BSI  hostility .32 (.39) .29 (.43) .32 (.40) N. S.  
BSI  phobic anxiety .14 (.31) .14 (.31) .14 (.29) N. S.  
BSI  paranoid ideation .32 (.40) .19 (.42) .32 (.44) F (2, 525) = 4.47**,  partial η2 = .017 Advanced < Early, Comparison 
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MEASURE 
Early 
Mean  (SD) 
Advanced 
Mean  (SD) 
Comparison 
Mean  (SD) 
MANOVA Analysis Post Hoc Analyses 
BSI  psychoticism .21 (.34) .17 (.32) .21 (.32) N. S.  
BSI  General Severity Index .34 (.35) .35 (.37) .34 (.35) N. S.  
      
DAS total 20.58 (4.45) 21.24 (4.42) 20.51 (4.25) N. S.  
       
FRI total score 9.59 (1.93) 9.70 (1.84) 9.22 (2.41) N. S.  
 
Note: SF-36 = Short Form 36-item Health Survey; BSI = Brief Symptom Index-53 item; DAS = Dyadic Adjustment Scale-short form; FRI = Family Relationship Index. 
* p < .05; ** p < .01; *** p < .001
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Table 3 
 
Number of participants in each group (early, advanced, and comparison) meeting DSM-IV diagnostic criteria for anxiety 
and depressive disorders using the CIDI.  
 
DSM-IV Psychiatric Disorder 
Early (n = 211) 
N (%) 
Advanced (n = 156) 
N (%) 
Comparison (n = 169) 
N (%) 
    
Panic disorder  2 0.9% 2 1.3% 1 0.6% 
Generalized anxiety disorder  5 2.4% 3 1.9% 2 1.2% 
Specific phobia  3 1.4% 2 1.3% 3 1.8% 
Social phobia  1 0.5% 2 1.3% 0     0% 
    
Major depression  6 2.8% 6 3.8% 7 4.1% 
Dysthymic disorder  2 0.9% 0     0% 3 1.8% 
    
 
 
